Prolonged-term therapy with ataluren delays loss of ambulation and would possibly perhaps well also extend decline in pulmonary feature in sufferers with nonsense mutation Duchenne…
Prolonged-term therapy with ataluren delays loss of ambulation and would possibly perhaps well also extend decline in pulmonary feature in sufferers with nonsense mutation Duchenne…